dpp 4 inhibitor and glp 1 receptor agonist combination Role of DPP-4 Inhibitors in Clinical Practice Dipeptidyl peptidase-4 inhibitor - Wikipedia
Description
A robust pipeline of entero-pancreatic hormone-based therapies is currently in development, with several dual and triple agonists expected to emerge for obesity in the coming years
Di Meco A, Curtis ME, Lauretti E, Pratico D
When you eat, your body releases GLP-1, which tells your brain youre full, slows stomach emptying, and helps regulate blood sugar by triggering insulin release
doi: 10.1677/jme.0.0100259 48 LupiRDel GuerraSDAleoVBoggiUFilipponiFMarchettiP
Neurology 102 , 3350 (2024)
is supported by the University of British Columbia Clinician Investigator Program and a Canadian Institutes of Health Research (CIHR) Canada Graduate ScholarshipMasters Award
